Drugs for Rare Diseases
All
Newsflash
Article
-
Japanese drugmaker Shionogi to acquire U.S.-based IntraBio for $2 billion to expand rare disease drug business
Japanese drugmaker Shionogi to acquire U.S.-based IntraBio for $2 billion to expand rare disease drug business
-
BioCryst Pharmaceuticals Achieves Profitability, Eyes Acquisitions of Rare Disease Drugs
BioCryst CEO Charlie Gayer stated that the company achieved profitability last year and expects to be more profitable this year and next. Its rare disease drug Orladeyo, approved by the FDA in 2020, h
-
Japanese drugmaker Shionogi to acquire U.S.-based IntraBio for $2 billion to expand rare disease drug business
Japanese drugmaker Shionogi to acquire U.S.-based IntraBio for $2 billion to expand rare disease drug business
-
BioCryst Pharmaceuticals Achieves Profitability, Eyes Acquisitions of Rare Disease Drugs
BioCryst CEO Charlie Gayer stated that the company achieved profitability last year and expects to be more profitable this year and next. Its rare disease drug Orladeyo, approved by the FDA in 2020, h
- No data
Drugs for Rare Diseases
Svmuu provides news and information related to Drugs for Rare Diseases, as well as real-time data on Drugs for Rare Diseases. We provide in-depth analysis and interpretation of the latest Drugs for Rare Diseases developments, helping investors stay informed about Drugs for Rare Diseases policy updates. Svmuu is your essential tool for keeping up with the latest Drugs for Rare Diseases trends! Here, we’ll join you in keeping a close eye on Drugs for Rare Diseases news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Anduril to Invest $6.6 Billion in Key Submarine Component Manufacturing for US Navy; HD Hyundai Open to Deeper Cooperation
-
2
IMF Managing Director Kristalina Georgieva: AI infrastructure investment drives global economic growth, expected to significantly boost growth rates in Asian economies.
-
3
Financial Stability Board Warns of Stablecoin and AI Risks Ahead of G20
-
4
Coinbase reports delays in ALEO transactions
-
5
Ledger confirms unauthorized hardware implant in a customer's wallet; independent investigators estimate cryptocurrency theft losses at $93.2 million.
-
6
Jefferies: A 5% yield on five-year U.S. Treasurys is an attractive level for long-term buyers.
-
7
Adidas CEO: Outdoor Sports and Street Dance to Drive New Growth in Chinese Market
-
8
Binance Futures Will Launch Multiple TradFi USDⓈ-Margined Perpetual Contracts (2026-10-12)
-
9
MAS to enhance safeguards for public prospecting activities
-
10
Multiple countries have warned their citizens to avoid traveling to Saudi Arabia after Houthi attacks on Riyadh airport resulted in multiple casualties and flight disruptions.
Markets Today
Recommended Reading
